Abstract
Objective: To describe a case of early-onset Alzheimer's disease (AD) in an apolipoprotein (Apo) ε2/ε2 homozygote. Background: Apo ε2/ε2 is the rarest of the ApoE genotypes, representing only 1.4% of the population. Cognitive decline in ApoE ε2 homozygotes has rarely been reported. Case Report/Methods: We report a 58-year-old Apo ε2/ε2 female who meets clinical criteria for probable AD as confirmed by neuropsychological testing, positron emission/computed tomography scan, CSF analysis and genetic screening for known mutations. Results: The clinical course is typical of AD, with progressive cognitive and functional decline. Conclusion: Clinically confirmed early-onset AD is atypical in ApoE2 homozygotes but can occur. © 2010 S. Karger AG, Basel.
Author supplied keywords
Cite
CITATION STYLE
Cole, L., Belden, C., Jacobson, S., Liebsack, C., Myers, K., Reninger, C., … Sabbagh, M. N. (2010). Probable early-onset alzheimer’s disease in an apolipoprotein E2 homozygote. Dementia and Geriatric Cognitive Disorders, 30(5), 387–391. https://doi.org/10.1159/000320589
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.